Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LongShengZhi Capsule for Functional Recovery in Acute Ischemic Stroke
NCT05277311Unknown
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- May 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial in ischemic stroke comparing LongShengZhi Capsule with Placebo (2 arms). Primary endpoint: Proportion of patients with excellent outcome at 90 days. Status: unknown.
02
Drugs
LongShengZhi
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT05277311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05277311.